Tempest Therapeutics (TPST) Change in Account Payables (2012 - 2025)

Tempest Therapeutics has reported Change in Account Payables for 14 years, with the latest figure at $116000.0 in Q4 2025.

• Quarterly Change in Account Payables fell 84.59% year-over-year to $116000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.4 million (down 187.98% YoY) and the FY2025 annual result came in at -$1.4 million, down 187.98% from the prior year.
• Change in Account Payables improved to $116000.0 in Q4 2025 per TPST's latest filing, from -$3.8 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $5.8 million in Q2 2021 and troughed at -$4.3 million in Q3 2021.
• A 5-year average of -$13900.0 and a median of $51000.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2021 and 2024: Change in Account Payables slumped 2901.95% in 2021, then surged 1616.67% in 2024.
• Over 5 years, Change in Account Payables stood at -$1.3 million in 2021, then soared by 106.72% to $90000.0 in 2022, then sank by 423.33% to -$291000.0 in 2023, then soared by 358.76% to $753000.0 in 2024, then tumbled by 84.59% to $116000.0 in 2025.
• According to Business Quant data, Change in Account Payables over the past three periods registered $116000.0, -$3.8 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.